Physician profile
Lori M Cheney
NPI 1497712293
$510.36
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $328 · 2021: $31.39 · 2022: $14.63.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $195.76 | 2019-2020 | |
| Pfizer INC. | $84.02 | 2019-2021 | |
| Novo Nordisk INC | $52.28 | 2019-2020 | |
| Lilly USA, LLC | $42.14 | 2020 | |
| Sunovion Pharmaceuticals INC. | $27.91 | 2020 | |
| Radius Health, INC. | $25.07 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.17 | 2019 | |
| Astellas Pharma US INC | $15.82 | 2019 | |
| Glaxosmithkline, LLC. | $14.96 | 2020 | |
| Abbott Laboratories | $14.63 | 2022 | |
| Allergan, INC. | $13.60 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Cheney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.